Furthermore, in the above experiments, we proved that ATP7A was the target of miR‐148a‐3p, and overexpressed miR‐148a‐3p increased the sensitivity of breast cancer cells to cisplatin via suppressing ATP7A. Here, ATP7A is linked to breast carcinoma.